Invention Grant
- Patent Title: Hepatitis C inhibitor compounds
- Patent Title (中): 丙型肝炎抑制剂化合物
-
Application No.: US11766171Application Date: 2007-06-21
-
Publication No.: US07939667B2Publication Date: 2011-05-10
- Inventor: Montse Llinas-Brunet , Murray Bailey , Punit Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
- Applicant: Montse Llinas-Brunet , Murray Bailey , Punit Bhardwaj , Josee Bordeleau , Pasquale Forgione , Elise Ghiro , Vida Gorys , Nathalie Goudreau , Sylvie Goulet , Teddy Halmos , Jean Rancourt
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Philip I. Datlow
- Main IPC: C07D215/38
- IPC: C07D215/38 ; A61K31/02
Abstract:
Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
Public/Granted literature
- US20070243166A1 Hepatitis C Inhibitor Compounds Public/Granted day:2007-10-18
Information query
